Terhi Kinnunen and Kate Kelland
February 1, 2011
- A d v e r t i s e m e n t
HELSINKI/LONDON, Feb 1 (Reuters) – Finland’s national health institute said on Tuesday preliminary research suggested children who got GlaxoSmithKline’s (GSK.L) Pandemrix vaccine against H1N1 pandemic flu were nine times more likely to suffer from a sleeping disorder called narcolepsy.
The research, which the institute said had yet to be confirmed, found an increase in cases of narcolepsy among children aged four to 19 years who had the vaccine.
Researchers at the National Institute for Health and Welfare (NIHW) said it was “most likely” the increase in narcolepsy was a joint effect of Pandemrix and some other factor or factors.
Our Christmas in July sale is now live! Get double Patriot Points and free shipping on our hottest products!